A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 270 participants.
Also called NCT07415954
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 270 participants
- Sponsor
- Registry
-
NCT07415954
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Croatia, Hungary, Japan, Poland, Portugal, Slovakia, South Korea, Spain, Thailand
- Registry status
- Recruiting
Technical summary
Registry record NCT07415954. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-17 (actual); primary completion 2027-09-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- NNC0662-0419
- Intervention (Drug)
- Semaglutide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct07415954- Content hash
9cc8de7df255ad5c5cbe27eb53296d0e0b87501998cfceae0bb32a80538f1eda